BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza
Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS).
RNA-mediated Interference | 12/07/2024 | By Aishwarya | 167
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy